Phase II Dose Titration Study in Patients With Neuropathic Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00736151
Recruitment Status : Completed
First Posted : August 15, 2008
Last Update Posted : August 7, 2009
Information provided by:
Newron Pharmaceuticals SPA

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2007
  Study Completion Date : No date given